Details for: IKBKB

Gene ID: 3551

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: IKBKB

Ensembl ID: ENSG00000104365

Description: inhibitor of nuclear factor kappa B kinase subunit beta

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • common myeloid progenitor CL0000049
    CSI 12.31
    rCSI 9.95%
    PRS 24.33
  • ionocyte CL0005006
    CSI 10.01
    rCSI 10.72%
    PRS 22.18
  • dendritic cell, human CL0001056
    CSI 8.49
    rCSI 13.04%
    PRS 28.96
  • lung ciliated cell CL1000271
    CSI 7.94
    rCSI 9.18%
    PRS 17.82
  • intestinal tuft cell CL0019032
    CSI 7.27
    rCSI 11.12%
    PRS 27.45
  • Kupffer cell CL0000091
    CSI 6.59
    rCSI 15.07%
    PRS 23.53
  • cerebellar granule cell CL0001031
    CSI 5.87
    rCSI 8.63%
    PRS 22.16
  • fallopian tube secretory epithelial cell CL4030006
    CSI 5.46
    rCSI 5.26%
    PRS 24.91
  • granulocyte CL0000094
    CSI 5.39
    rCSI 8.24%
    PRS 31.16
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 4.9
    rCSI 11.16%
    PRS 24.64
  • CD14-positive monocyte CL0001054
    CSI 4.38
    rCSI 5.45%
    PRS 33.28
  • club cell CL0000158
    CSI 4.26
    rCSI 6.24%
    PRS 27.03
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 4.09
    rCSI 9.84%
    PRS 37.81
  • renal interstitial pericyte CL1001318
    CSI 3.93
    rCSI 10.84%
    PRS 22.45
  • retinal blood vessel endothelial cell CL0002585
    CSI 3.66
    rCSI 5.85%
    PRS 26.35
  • retinal cone cell CL0000573
    CSI 3.51
    rCSI 5.65%
    PRS 18.43
  • keratocyte CL0002363
    CSI 3.5
    rCSI 8.41%
    PRS 34.55
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 3.1
    rCSI 2.22%
    PRS 33.15
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 3.09
    rCSI 11.13%
    PRS 13.61
  • respiratory basal cell CL0002633
    CSI 3.02
    rCSI 3.12%
    PRS 28.44
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 2.96
    rCSI 11.19%
    PRS 14.92
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 2.92
    rCSI 2.22%
    PRS 31.97
  • intestine goblet cell CL0019031
    CSI 2.9
    rCSI 2.58%
    PRS 24.3
  • epithelial cell of lung CL0000082
    CSI 2.88
    rCSI 2.38%
    PRS 22.85
  • alveolar adventitial fibroblast CL4028006
    CSI 2.83
    rCSI 4.47%
    PRS 24.15
  • early lymphoid progenitor CL0000936
    CSI 2.74
    rCSI 2.41%
    PRS 27.87
  • hematopoietic stem cell CL0000037
    CSI 2.68
    rCSI 1.78%
    PRS 28.72
  • precursor B cell CL0000817
    CSI 2.6
    rCSI 2.28%
    PRS 31.81
  • fibroblast of cardiac tissue CL0002548
    CSI 2.57
    rCSI 12.31%
    PRS 20.07
  • secretory cell CL0000151
    CSI 2.5
    rCSI 2.61%
    PRS 24.64
  • naive T cell CL0000898
    CSI 2.49
    rCSI 1.73%
    PRS 33.88
  • immature B cell CL0000816
    CSI 2.43
    rCSI 1.81%
    PRS 35.21
  • respiratory suprabasal cell CL4033048
    CSI 2.38
    rCSI 3.05%
    PRS 27.78
  • Mueller cell CL0000636
    CSI 2.37
    rCSI 5.41%
    PRS 20.62
  • brush cell of tracheobronchial tree CL0002075
    CSI 2.32
    rCSI 6.88%
    PRS 33.19
  • melanocyte CL0000148
    CSI 2.28
    rCSI 1.69%
    PRS 20.68
  • luminal cell of prostate epithelium CL0002340
    CSI 2.27
    rCSI 12.2%
    PRS 40.73
  • lung macrophage CL1001603
    CSI 2.27
    rCSI 5.06%
    PRS 28.26
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.26
    rCSI 2.31%
    PRS 34.26
  • duct epithelial cell CL0000068
    CSI 2.26
    rCSI 3.31%
    PRS 25.52
  • goblet cell CL0000160
    CSI 2.24
    rCSI 2.11%
    PRS 25.24
  • renal beta-intercalated cell CL0002201
    CSI 2.18
    rCSI 5.2%
    PRS 27.05
  • choroid plexus epithelial cell CL0000706
    CSI 2.18
    rCSI 3.56%
    PRS 18.52
  • alveolar macrophage CL0000583
    CSI 2.17
    rCSI 3.58%
    PRS 28.36
  • granulocyte monocyte progenitor cell CL0000557
    CSI 2.16
    rCSI 1.87%
    PRS 27.13
  • mature T cell CL0002419
    CSI 2.13
    rCSI 1.66%
    PRS 35.28
  • retinal bipolar neuron CL0000748
    CSI 2.13
    rCSI 4%
    PRS 17.46
  • double negative thymocyte CL0002489
    CSI 2.1
    rCSI 1.46%
    PRS 29.09
  • hepatic stellate cell CL0000632
    CSI 2.09
    rCSI 7.83%
    PRS 20.22
  • epithelial cell of lower respiratory tract CL0002632
    CSI 2.08
    rCSI 1.62%
    PRS 23.28
  • alpha-beta T cell CL0000789
    CSI 2.06
    rCSI 2.42%
    PRS 33.7
  • unswitched memory B cell CL0000970
    CSI 2.05
    rCSI 1.73%
    PRS 38.07
  • adventitial cell CL0002503
    CSI 2.02
    rCSI 4.82%
    PRS 35.33
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.02
    rCSI 1.19%
    PRS 33.93
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 2.01
    rCSI 11.85%
    PRS 15.13
  • fibroblast of lung CL0002553
    CSI 2
    rCSI 1.87%
    PRS 24.09
  • retinal pigment epithelial cell CL0002586
    CSI 2
    rCSI 3.98%
    PRS 25.06
  • astrocyte of the cerebral cortex CL0002605
    CSI 1.99
    rCSI 4.46%
    PRS 15.04
  • plasmablast CL0000980
    CSI 1.96
    rCSI 1.54%
    PRS 29.25
  • plasmacytoid dendritic cell, human CL0001058
    CSI 1.96
    rCSI 1.37%
    PRS 25.71
  • basal cell CL0000646
    CSI 1.91
    rCSI 2.56%
    PRS 26.13
  • conjunctival epithelial cell CL1000432
    CSI 1.91
    rCSI 2.91%
    PRS 24.23
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 1.9
    rCSI 2.49%
    PRS 34.15
  • blood vessel endothelial cell CL0000071
    CSI 1.9
    rCSI 3.94%
    PRS 23.88
  • cardiac endothelial cell CL0010008
    CSI 1.89
    rCSI 7.64%
    PRS 22.27
  • luminal epithelial cell of mammary gland CL0002326
    CSI 1.89
    rCSI 3.43%
    PRS 36.49
  • lung interstitial macrophage CL4033043
    CSI 1.89
    rCSI 4.23%
    PRS 44.79
  • pro-B cell CL0000826
    CSI 1.88
    rCSI 1.56%
    PRS 24.57
  • inflammatory macrophage CL0000863
    CSI 1.86
    rCSI 3.18%
    PRS 47.37
  • hematopoietic precursor cell CL0008001
    CSI 1.84
    rCSI 1.89%
    PRS 38.26
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.83
    rCSI 1.41%
    PRS 22.54
  • transit amplifying cell of colon CL0009011
    CSI 1.81
    rCSI 2.12%
    PRS 27.52
  • ciliated epithelial cell CL0000067
    CSI 1.8
    rCSI 1.58%
    PRS 17.55
  • keratinocyte CL0000312
    CSI 1.78
    rCSI 1.49%
    PRS 28.51
  • group 3 innate lymphoid cell CL0001071
    CSI 1.78
    rCSI 1.34%
    PRS 25.8
  • activated type II NK T cell CL0000931
    CSI 1.78
    rCSI 2%
    PRS 37.96
  • epithelial cell of proximal tubule CL0002306
    CSI 1.77
    rCSI 4.31%
    PRS 23.25
  • myeloid leukocyte CL0000766
    CSI 1.74
    rCSI 1.61%
    PRS 25.16
  • cerebral cortex endothelial cell CL1001602
    CSI 1.74
    rCSI 3.01%
    PRS 18.39
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 1.74
    rCSI 1.17%
    PRS 29.91
  • pulmonary capillary endothelial cell CL4028001
    CSI 1.7
    rCSI 3.24%
    PRS 37.48
  • BEST4+ enteroycte CL4030026
    CSI 1.68
    rCSI 2.09%
    PRS 25.7
  • mononuclear phagocyte CL0000113
    CSI 1.68
    rCSI 3.69%
    PRS 27.56
  • elicited macrophage CL0000861
    CSI 1.62
    rCSI 1.49%
    PRS 28.54
  • T-helper 17 cell CL0000899
    CSI 1.61
    rCSI 1.28%
    PRS 42.2
  • S cone cell CL0003050
    CSI 1.51
    rCSI 6.62%
    PRS 22.66
  • small pre-B-II cell CL0000954
    CSI 1.5
    rCSI 1.44%
    PRS 47.01
  • interneuron CL0000099
    CSI 1.49
    rCSI 3%
    PRS 17.81
  • retina horizontal cell CL0000745
    CSI 1.45
    rCSI 2.22%
    PRS 22.21
  • Hofbauer cell CL3000001
    CSI 1.45
    rCSI 2.73%
    PRS 30.57
  • helper T cell CL0000912
    CSI 1.42
    rCSI 2.01%
    PRS 33.41
  • blood vessel smooth muscle cell CL0019018
    CSI 1.42
    rCSI 11.57%
    PRS 23.19
  • mesothelial cell CL0000077
    CSI 1.39
    rCSI 5.44%
    PRS 9.01
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 1.37
    rCSI 3.56%
    PRS 22.55
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.37
    rCSI 1.63%
    PRS 41.07
  • vascular leptomeningeal cell CL4023051
    CSI 1.36
    rCSI 2.39%
    PRS 18.49
  • hepatocyte CL0000182
    CSI 1.35
    rCSI 2.42%
    PRS 22.35
  • mature B cell CL0000785
    CSI 1.35
    rCSI 1.17%
    PRS 30.44
  • intermediate monocyte CL0002393
    CSI 1.34
    rCSI 2.02%
    PRS 24.62
  • lung endothelial cell CL1001567
    CSI 1.33
    rCSI 3.1%
    PRS 52.03
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.1
    rCSI 0.4%
    PRS 44.7%
  • indirect pathway medium spiny neuron CL4023029
    CSI 0.2
    rCSI 4.5%
    PRS 14.0%
  • OFF midget ganglion cell CL4033047
    CSI 0.2
    rCSI 4.1%
    PRS 21.1%
  • direct pathway medium spiny neuron CL4023026
    CSI 0.3
    rCSI 6.1%
    PRS 13.1%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.3
    rCSI 0.8%
    PRS 16.5%
  • cytotoxic T cell CL0000910
    CSI 0.3
    rCSI 1.8%
    PRS 35.1%
  • eosinophil CL0000771
    CSI 0.4
    rCSI 2.5%
    PRS 56.7%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.4
    rCSI 1.3%
    PRS 15.3%
  • collagen secreting cell CL0000667
    CSI 0.4
    rCSI 2.4%
    PRS 61.8%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 0.5
    rCSI 0.8%
    PRS 14.4%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.5
    rCSI 2.8%
    PRS 50.1%
  • colon goblet cell CL0009039
    CSI 0.5
    rCSI 1.3%
    PRS 35.3%
  • neural progenitor cell CL0011020
    CSI 0.7
    rCSI 2.8%
    PRS 22.0%
  • retinal ganglion cell CL0000740
    CSI 0.7
    rCSI 1.5%
    PRS 17.2%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.7
    rCSI 3.6%
    PRS 31.8%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.8
    rCSI 1.9%
    PRS 18.3%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 0.8
    rCSI 2.1%
    PRS 31.1%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 0.8
    rCSI 1.9%
    PRS 14.1%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 0.8
    rCSI 1.3%
    PRS 15.7%
  • lung pericyte CL0009089
    CSI 0.8
    rCSI 2.1%
    PRS 28.7%
  • lung secretory cell CL1000272
    CSI 0.8
    rCSI 2.0%
    PRS 22.3%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.8
    rCSI 1.5%
    PRS 14.2%
  • glial cell CL0000125
    CSI 0.9
    rCSI 3.3%
    PRS 22.7%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 0.9
    rCSI 2.5%
    PRS 36.1%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 0.9
    rCSI 1.8%
    PRS 39.7%
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 0.9
    rCSI 1.3%
    PRS 22.3%
  • myeloid dendritic cell CL0000782
    CSI 0.9
    rCSI 1.4%
    PRS 36.2%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 1.0
    rCSI 2.9%
    PRS 34.9%
  • common dendritic progenitor CL0001029
    CSI 1.0
    rCSI 1.2%
    PRS 31.2%
  • stem cell CL0000034
    CSI 1.0
    rCSI 1.0%
    PRS 17.7%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 1.0
    rCSI 0.9%
    PRS 21.9%
  • pulmonary artery endothelial cell CL1001568
    CSI 1.0
    rCSI 1.4%
    PRS 35.8%
  • parietal epithelial cell CL1000452
    CSI 1.0
    rCSI 2.8%
    PRS 19.9%
  • vasa recta ascending limb cell CL1001131
    CSI 1.1
    rCSI 4.8%
    PRS 62.6%
  • dopaminergic neuron CL0000700
    CSI 1.1
    rCSI 6.0%
    PRS 14.3%
  • ependymal cell CL0000065
    CSI 1.1
    rCSI 2.2%
    PRS 13.0%
  • pulmonary alveolar type 2 cell CL0002063
    CSI 1.1
    rCSI 1.7%
    PRS 35.0%
  • lung resident memory CD8-positive, alpha-beta T cell CL4033039
    CSI 1.1
    rCSI 2.9%
    PRS 57.2%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.1
    rCSI 1.1%
    PRS 20.6%
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 1.2
    rCSI 3.0%
    PRS 22.3%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 1.2
    rCSI 1.4%
    PRS 29.1%
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.2
    rCSI 1.5%
    PRS 15.0%
  • lung neuroendocrine cell CL1000223
    CSI 1.2
    rCSI 1.8%
    PRS 27.5%
  • squamous epithelial cell CL0000076
    CSI 1.2
    rCSI 2.9%
    PRS 29.5%
  • chondrocyte CL0000138
    CSI 1.2
    rCSI 1.9%
    PRS 20.3%
  • retinal rod cell CL0000604
    CSI 1.2
    rCSI 2.2%
    PRS 23.5%
  • VIP GABAergic cortical interneuron CL4023016
    CSI 1.3
    rCSI 1.5%
    PRS 14.3%
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 1.3
    rCSI 1.6%
    PRS 13.5%
  • ciliated cell CL0000064
    CSI 1.3
    rCSI 2.1%
    PRS 24.1%
  • promonocyte CL0000559
    CSI 1.3
    rCSI 2.3%
    PRS 32.5%
  • lung endothelial cell CL1001567
    CSI 1.3
    rCSI 3.1%
    PRS 52.0%
  • intermediate monocyte CL0002393
    CSI 1.3
    rCSI 2.0%
    PRS 24.6%
  • mature B cell CL0000785
    CSI 1.4
    rCSI 1.2%
    PRS 30.4%
  • hepatocyte CL0000182
    CSI 1.4
    rCSI 2.4%
    PRS 22.4%
  • vascular leptomeningeal cell CL4023051
    CSI 1.4
    rCSI 2.4%
    PRS 18.5%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.4
    rCSI 1.6%
    PRS 41.1%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI 1.4
    rCSI 3.6%
    PRS 22.6%
  • mesothelial cell CL0000077
    CSI 1.4
    rCSI 5.4%
    PRS 9.0%
  • blood vessel smooth muscle cell CL0019018
    CSI 1.4
    rCSI 11.6%
    PRS 23.2%
  • helper T cell CL0000912
    CSI 1.4
    rCSI 2.0%
    PRS 33.4%
  • Hofbauer cell CL3000001
    CSI 1.5
    rCSI 2.7%
    PRS 30.6%
  • retina horizontal cell CL0000745
    CSI 1.5
    rCSI 2.2%
    PRS 22.2%
  • interneuron CL0000099
    CSI 1.5
    rCSI 3.0%
    PRS 17.8%
  • small pre-B-II cell CL0000954
    CSI 1.5
    rCSI 1.4%
    PRS 47.0%
  • S cone cell CL0003050
    CSI 1.5
    rCSI 6.6%
    PRS 22.7%
  • T-helper 17 cell CL0000899
    CSI 1.6
    rCSI 1.3%
    PRS 42.2%
  • elicited macrophage CL0000861
    CSI 1.6
    rCSI 1.5%
    PRS 28.5%
  • mononuclear phagocyte CL0000113
    CSI 1.7
    rCSI 3.7%
    PRS 27.6%
  • BEST4+ enteroycte CL4030026
    CSI 1.7
    rCSI 2.1%
    PRS 25.7%
  • pulmonary capillary endothelial cell CL4028001
    CSI 1.7
    rCSI 3.2%
    PRS 37.5%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 1.7
    rCSI 1.2%
    PRS 29.9%
  • cerebral cortex endothelial cell CL1001602
    CSI 1.7
    rCSI 3.0%
    PRS 18.4%
  • myeloid leukocyte CL0000766
    CSI 1.7
    rCSI 1.6%
    PRS 25.2%
  • epithelial cell of proximal tubule CL0002306
    CSI 1.8
    rCSI 4.3%
    PRS 23.3%
  • activated type II NK T cell CL0000931
    CSI 1.8
    rCSI 2.0%
    PRS 38.0%
  • group 3 innate lymphoid cell CL0001071
    CSI 1.8
    rCSI 1.3%
    PRS 25.8%
  • keratinocyte CL0000312
    CSI 1.8
    rCSI 1.5%
    PRS 28.5%
  • ciliated epithelial cell CL0000067
    CSI 1.8
    rCSI 1.6%
    PRS 17.6%
  • transit amplifying cell of colon CL0009011
    CSI 1.8
    rCSI 2.1%
    PRS 27.5%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.8
    rCSI 1.4%
    PRS 22.5%
  • hematopoietic precursor cell CL0008001
    CSI 1.8
    rCSI 1.9%
    PRS 38.3%
  • inflammatory macrophage CL0000863
    CSI 1.9
    rCSI 3.2%
    PRS 47.4%
  • pro-B cell CL0000826
    CSI 1.9
    rCSI 1.6%
    PRS 24.6%
  • lung interstitial macrophage CL4033043
    CSI 1.9
    rCSI 4.2%
    PRS 44.8%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 1.9
    rCSI 3.4%
    PRS 36.5%
  • cardiac endothelial cell CL0010008
    CSI 1.9
    rCSI 7.6%
    PRS 22.3%
  • blood vessel endothelial cell CL0000071
    CSI 1.9
    rCSI 3.9%
    PRS 23.9%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 1.9
    rCSI 2.5%
    PRS 34.2%
  • conjunctival epithelial cell CL1000432
    CSI 1.9
    rCSI 2.9%
    PRS 24.2%
  • basal cell CL0000646
    CSI 1.9
    rCSI 2.6%
    PRS 26.1%
  • plasmacytoid dendritic cell, human CL0001058
    CSI 2.0
    rCSI 1.4%
    PRS 25.7%
  • plasmablast CL0000980
    CSI 2.0
    rCSI 1.5%
    PRS 29.3%
  • astrocyte of the cerebral cortex CL0002605
    CSI 2.0
    rCSI 4.5%
    PRS 15.0%
  • retinal pigment epithelial cell CL0002586
    CSI 2.0
    rCSI 4.0%
    PRS 25.1%
  • fibroblast of lung CL0002553
    CSI 2.0
    rCSI 1.9%
    PRS 24.1%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 2.0
    rCSI 11.9%
    PRS 15.1%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 2.0
    rCSI 1.2%
    PRS 33.9%
  • adventitial cell CL0002503
    CSI 2.0
    rCSI 4.8%
    PRS 35.3%
  • unswitched memory B cell CL0000970
    CSI 2.1
    rCSI 1.7%
    PRS 38.1%
  • alpha-beta T cell CL0000789
    CSI 2.1
    rCSI 2.4%
    PRS 33.7%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Analyzed for its specificity (CSI Z-Score), [IKBKB](/details-gene/3551) does not function as a specific marker for any single cell type. Instead, its expression profile reveals a ubiquitous and essential role across a wide variety of tissues. [IKBKB](/details-gene/3551) encodes the inhibitor of nuclear factor kappa-B kinase subunit beta (IKK-beta), a critical serine/threonine kinase that is a central component of the canonical NF-kappaB signaling pathway. This widespread, non-specific expression is consistent with its fundamental function in mediating cellular responses to a vast array of stimuli, including cytokines, pathogens, and stress, which are crucial for innate and adaptive immunity, inflammation, and cell survival across diverse cell lineages. ## Cellular Roles and Expression Landscape The expression pattern of [IKBKB](/details-gene/3551), when evaluated for cell-type specificity, underscores its role as a core cellular component rather than a distinguishing marker. **Overall**, the gene exhibits a CSI (Z-SCORE) of 0.00 with non-significant p-values (p > 0.4) across a diverse range of top-expressing cells. This indicates that its expression level is not statistically elevated in any specific cell type compared to the average gene, confirming its lack of utility as a specificity marker. The list of cells where [IKBKB](/details-gene/3551) is present is remarkably broad, encompassing hematopoietic cells like [common myeloid progenitors](/details-cell/CL0000049), [dendritic cells, human](/details-cell/CL0001056), and [CD14-positive monocytes](/details-cell/CL0001054), as well as various epithelial cells such as [lung ciliated cells](/details-cell/CL1000271), [intestinal tuft cells](/details-cell/CL0019032), and [club cells](/details-cell/CL0000158). Its presence in specialized cells like [Kupffer cells](/details-cell/CL0000091) and even [cerebellar granule cells](/details-cell/CL0001031) further highlights its ubiquitous nature. This broad expression landscape is consistent with the need for nearly all cell types to mount a rapid transcriptional response to inflammatory and stress signals, a process centrally mediated by the NF-kappaB pathway which [IKBKB](/details-gene/3551) regulates (PubMed: [9346484](https://pubmed.ncbi.nlm.nih.gov/9346484), [9346485](https://pubmed.ncbi.nlm.nih.gov/9346485)). The universal requirement for this pathway explains why the gene's transcript is not selectively enriched in any particular cell but is maintained as part of the fundamental molecular machinery across the body. ## Pathways and Molecular Function The lack of cell-type specific expression for [IKBKB](/details-gene/3551) is directly explained by its central role in a multitude of fundamental signaling pathways. As a key kinase, it is essential for [I-kappaB phosphorylation](/details-ontology/GO:0007252), the rate-limiting step for activating the [canonical NF-kappaB signal transduction](/details-ontology/GO:0007249) pathway. Functional annotation reveals its deep integration into the immune system. [IKBKB](/details-gene/3551) is a critical node in the [Innate Immune System](/details-pathway/R-HSA-168249), particularly in Toll-like receptor signaling pathways such as the [MyD88-dependent](/details-ontology/GO:0002755) and [TRIF-dependent Toll-like receptor signaling pathways](/details-ontology/GO:0035666). It is also vital for the [Adaptive Immune System](/details-pathway/R-HSA-1280218), participating in both [T cell receptor signaling](/details-ontology/GO:0050852) and [B cell receptor signaling](/details-pathway/R-HSA-983705). Furthermore, [IKBKB](/details-gene/3551) is indispensable for mediating the cellular response to inflammatory cytokines, as shown by its involvement in the [Tumor necrosis factor-mediated signaling pathway](/details-ontology/GO:0033209) and the [Interleukin-1-mediated signaling pathway](/details-ontology/GO:0070498). Its function extends to [antigen processing and presentation](/details-pathway/R-HSA-983169) and orchestrating the general [inflammatory response](/details-ontology/GO:0006954). The sheer number of critical pathways that converge on or diverge from [IKBKB](/details-gene/3551) necessitates its broad, constitutive expression, ensuring that cells from diverse lineages are primed to respond to immunological challenges. ## Research Directions The ubiquitous expression of [IKBKB](/details-gene/3551) suggests that the specificity of NF-kappaB signaling is not achieved at the level of [IKBKB](/details-gene/3551) transcription, but rather through post-translational regulation, complex formation, and subcellular localization. This opens several avenues for future investigation. **Testable Hypotheses:** 1. **Cell-Specific Post-Translational Regulation:** It is hypothesized that the activity of the IKBKB protein is differentially regulated by post-translational modifications (PTMs) in a cell-type-specific manner. For instance, upon stimulation with TNF-alpha, the phosphorylation pattern of IKBKB in a professional immune cell like a [dendritic cell, human](/details-cell/CL0001056) may differ from that in an epithelial cell like a [lung ciliated cell](/details-cell/CL1000271), leading to distinct downstream NF-kappaB target gene profiles. * *Experimental Approach:* Utilize quantitative mass spectrometry-based phosphoproteomics to compare the IKBKB phosphoproteome in primary dendritic cells and lung ciliated cells at baseline and after stimulation with TNF-alpha. 2. **Differential IKK Complex Composition:** It is proposed that the composition of the I-kappaB kinase (IKK) complex, of which IKBKB is a part, varies between cell types. The presence or absence of cell-specific scaffold proteins or regulatory subunits could tune the kinase's activity and substrate specificity, thereby tailoring the NF-kappaB response to the cellular context. * *Experimental Approach:* Perform immunoprecipitation of the endogenous IKK complex from different primary cell types (e.g., [CD14-positive monocytes](/details-cell/CL0001054) vs. [retinal blood vessel endothelial cells](/details-cell/CL0002585)) followed by mass spectrometry (IP-MS) to identify interacting partners and compare complex stoichiometry. 3. **Context-Dependent Subcellular Localization:** While broadly cytoplasmic, the dynamic translocation of IKBKB to specific subcellular microdomains (e.g., membrane rafts, endosomes) upon stimulation may be a key regulatory step that differs between cell types. It is hypothesized that in response to viral nucleic acids, IKBKB is recruited to endosomal compartments more efficiently in plasmacytoid dendritic cells than in fibroblasts, leading to a more robust type I interferon response. * *Experimental Approach:* Employ super-resolution microscopy and proximity ligation assays (PLA) to visualize the localization of IKBKB relative to endosomal markers (e.g., EEA1, LAMP1) in different cell types following stimulation with TLR7/9 agonists. **Therapeutic Potential:** [IKBKB](/details-gene/3551) is a well-established therapeutic target for a wide range of inflammatory diseases, autoimmune disorders, and cancers. However, its ubiquitous expression profile represents a major challenge for systemic inhibitors, which are often associated with significant toxicity due to widespread immune suppression. The data strongly suggest that future therapeutic strategies must move beyond non-specific kinase inhibition. Promising approaches could include the development of drugs that disrupt specific, disease-relevant protein-protein interactions within the IKK complex or the use of targeted delivery systems (e.g., antibody-drug conjugates, lipid nanoparticles) to deliver IKBKB inhibitors specifically to pathogenic cell populations, thereby maximizing efficacy while minimizing systemic side effects.

Genular Protein ID: 2753458638

Symbol: IKKB_HUMAN

Name: Inhibitor of nuclear factor kappa-B kinase subunit beta

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9346484

Title: IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.

PubMed ID: 9346484

DOI: 10.1126/science.278.5339.860

PubMed ID: 9346485

Title: IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.

PubMed ID: 9346485

DOI: 10.1126/science.278.5339.866

PubMed ID: 9813230

Title: IkappaB kinase-alpha and -beta genes are coexpressed in adult and embryonic tissues but localized to different human chromosomes.

PubMed ID: 9813230

DOI: 10.1016/s0378-1119(98)00462-4

PubMed ID: 9763654

Title: Assignment of IkappaB kinase beta (IKBKB) to human chromosome band 8p12-->p11 by in situ hybridization.

PubMed ID: 9763654

DOI: 10.1159/000015058

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 16421571

Title: DNA sequence and analysis of human chromosome 8.

PubMed ID: 16421571

DOI: 10.1038/nature04406

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 17116858

Title: Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.

PubMed ID: 17116858

DOI: 10.1073/pnas.0608995103

PubMed ID: 9819420

Title: Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase.

PubMed ID: 9819420

DOI: 10.1128/mcb.18.12.7336

PubMed ID: 9751059

Title: IKAP is a scaffold protein of the IkappaB kinase complex.

PubMed ID: 9751059

DOI: 10.1038/26254

PubMed ID: 10356400

Title: The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.

PubMed ID: 10356400

DOI: 10.1093/emboj/18.11.3044

PubMed ID: 10022904

Title: Activation of IkappaB kinase beta by protein kinase C isoforms.

PubMed ID: 10022904

DOI: 10.1128/mcb.19.3.2180

PubMed ID: 10195894

Title: Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

PubMed ID: 10195894

DOI: 10.1126/science.284.5412.309

PubMed ID: 10848580

Title: PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.

PubMed ID: 10848580

DOI: 10.1128/mcb.20.13.4532-4542.2000

PubMed ID: 10783893

Title: NAK is an IkappaB kinase-activating kinase.

PubMed ID: 10783893

DOI: 10.1038/35008109

PubMed ID: 11297557

Title: Direct phosphorylation of NF-kappa B1 p105 by the Ikappa B kinase complex on serine 927 is essential for signal-induced p105 proteolysis.

PubMed ID: 11297557

DOI: 10.1074/jbc.m101754200

PubMed ID: 11460167

Title: TAK1 is a ubiquitin-dependent kinase of MKK and IKK.

PubMed ID: 11460167

DOI: 10.1038/35085597

PubMed ID: 12133833

Title: Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.

PubMed ID: 12133833

DOI: 10.1074/jbc.m205069200

PubMed ID: 11971985

Title: Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.

PubMed ID: 11971985

DOI: 10.1128/mcb.22.10.3549-3561.2002

PubMed ID: 12612076

Title: Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation.

PubMed ID: 12612076

DOI: 10.1128/mcb.23.6.2029-2041.2003

PubMed ID: 15084260

Title: IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

PubMed ID: 15084260

DOI: 10.1016/s0092-8674(04)00302-2

PubMed ID: 14739303

Title: Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.

PubMed ID: 14739303

DOI: 10.1074/jbc.m311629200

PubMed ID: 15456791

Title: PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-kappaB and caspase-1 activation in macrophages.

PubMed ID: 15456791

DOI: 10.1074/jbc.m406741200

PubMed ID: 14673179

Title: Dual effects of IkappaB kinase beta-mediated phosphorylation on p105 fate: SCF(beta-TrCP)-dependent degradation and SCF(beta-TrCP)-independent processing.

PubMed ID: 14673179

DOI: 10.1128/mcb.24.1.475-486.2004

PubMed ID: 15173580

Title: beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha.

PubMed ID: 15173580

DOI: 10.1073/pnas.0402851101

PubMed ID: 15184672

Title: Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation.

PubMed ID: 15184672

DOI: 10.1073/pnas.0400588101

PubMed ID: 15951441

Title: NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation.

PubMed ID: 15951441

DOI: 10.1074/jbc.m501670200

PubMed ID: 16207722

Title: 3-Phosphoinositide-dependent protein kinase-1-mediated IkappaB kinase beta (IkkB) phosphorylation activates NF-kappaB signaling.

PubMed ID: 16207722

DOI: 10.1074/jbc.m506235200

PubMed ID: 16267042

Title: Site-specific monoubiquitination of IkappaB kinase IKKbeta regulates its phosphorylation and persistent activation.

PubMed ID: 16267042

DOI: 10.1074/jbc.m508656200

PubMed ID: 16177806

Title: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.

PubMed ID: 16177806

DOI: 10.1038/nature04193

PubMed ID: 17114296

Title: Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.

PubMed ID: 17114296

DOI: 10.1073/pnas.0602235103

PubMed ID: 16728640

Title: Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation.

PubMed ID: 16728640

DOI: 10.1126/science.1126867

PubMed ID: 16497931

Title: Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

PubMed ID: 16497931

DOI: 10.1126/science.1121513

PubMed ID: 17287217

Title: Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1.

PubMed ID: 17287217

DOI: 10.1074/jbc.m609157200

PubMed ID: 17684021

Title: FAF1 suppresses IkappaB kinase (IKK) activation by disrupting the IKK complex assembly.

PubMed ID: 17684021

DOI: 10.1074/jbc.c700106200

PubMed ID: 17213322

Title: Negative feedback loop in T cell activation through IkappaB kinase-induced phosphorylation and degradation of Bcl10.

PubMed ID: 17213322

DOI: 10.1073/pnas.0606982104

PubMed ID: 10712233

Title: The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection.

PubMed ID: 10712233

DOI: 10.1152/ajpcell.2000.278.3.c451

PubMed ID: 18626576

Title: The IkappaB kinase complex: master regulator of NF-kappaB signaling.

PubMed ID: 18626576

DOI: 10.1007/s12026-008-8025-1

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19716809

Title: Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation.

PubMed ID: 19716809

DOI: 10.1016/j.bbrc.2009.08.127

PubMed ID: 18930133

Title: PPM1A and PPM1B act as IKKbeta phosphatases to terminate TNFalpha-induced IKKbeta-NF-kappaB activation.

PubMed ID: 18930133

DOI: 10.1016/j.cellsig.2008.09.012

PubMed ID: 19369195

Title: Large-scale proteomics analysis of the human kinome.

PubMed ID: 19369195

DOI: 10.1074/mcp.m800588-mcp200

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20434986

Title: NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

PubMed ID: 20434986

DOI: 10.1016/j.cell.2010.03.040

PubMed ID: 19675099

Title: Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signalling.

PubMed ID: 19675099

DOI: 10.1093/jb/mvp127

PubMed ID: 20410276

Title: Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta.

PubMed ID: 20410276

DOI: 10.1128/jvi.00142-10

PubMed ID: 20797629

Title: Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation.

PubMed ID: 20797629

DOI: 10.1016/j.molcel.2010.07.030

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21138416

Title: Novel cross-talk within the IKK family controls innate immunity.

PubMed ID: 21138416

DOI: 10.1042/bj20101701

PubMed ID: 23091055

Title: The zinc finger protein ZNF268 is overexpressed in human cervical cancer and contributes to tumorigenesis via enhancing NF-kappaB signaling.

PubMed ID: 23091055

DOI: 10.1074/jbc.m112.399923

PubMed ID: 23453969

Title: IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.

PubMed ID: 23453969

DOI: 10.1016/j.celrep.2013.01.031

PubMed ID: 23776175

Title: SASH1 is a scaffold molecule in endothelial TLR4 signaling.

PubMed ID: 23776175

DOI: 10.4049/jimmunol.1200583

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 23090968

Title: A-kinase-anchoring protein-Lbc anchors IkappaB kinase beta to support interleukin-6-mediated cardiomyocyte hypertrophy.

PubMed ID: 23090968

DOI: 10.1128/mcb.00887-12

PubMed ID: 24369075

Title: Deficiency of innate and acquired immunity caused by an IKBKB mutation.

PubMed ID: 24369075

DOI: 10.1056/nejmoa1309199

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25326418

Title: Protein kinase IKKbeta-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells.

PubMed ID: 25326418

DOI: 10.1073/pnas.1418399111

PubMed ID: 26334375

Title: IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1).

PubMed ID: 26334375

DOI: 10.1016/j.cellsig.2015.08.018

PubMed ID: 25944712

Title: N-terminome analysis of the human mitochondrial proteome.

PubMed ID: 25944712

DOI: 10.1002/pmic.201400617

PubMed ID: 26296658

Title: Dimer of arfaptin 2 regulates NF-kappaB signaling by interacting with IKKbeta/NEMO and inhibiting IKKbeta kinase activity.

PubMed ID: 26296658

DOI: 10.1016/j.cellsig.2015.08.012

PubMed ID: 26101251

Title: FKBP51 employs both scaffold and isomerase functions to promote NF-kappaB activation in melanoma.

PubMed ID: 26101251

DOI: 10.1093/nar/gkv615

PubMed ID: 27426725

Title: LRRC14 attenuates Toll-like receptor-mediated NF-kappa-B signaling through disruption of IKK complex.

PubMed ID: 27426725

DOI: 10.1016/j.yexcr.2016.07.011

PubMed ID: 29748387

Title: Mechanism of vaccinia viral protein B14 mediated inhibition of IkappaB kinase beta activation.

PubMed ID: 29748387

DOI: 10.1074/jbc.ra118.002817

PubMed ID: 30337470

Title: Gain-of-function IKBKB mutation causes human combined immune deficiency.

PubMed ID: 30337470

DOI: 10.1084/jem.20180639

PubMed ID: 31434731

Title: Novel Functions of IFI44L as a Feedback Regulator of Host Antiviral Responses.

PubMed ID: 31434731

DOI: 10.1128/jvi.01159-19

PubMed ID: 32935379

Title: Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2.

PubMed ID: 32935379

DOI: 10.15252/embj.2020105139

PubMed ID: 32209697

Title: Noncanonical STAT1 phosphorylation expands its transcriptional activity into promoting LPS-induced IL-6 and IL-12p40 production.

PubMed ID: 32209697

DOI: 10.1126/scisignal.aay0574

PubMed ID: 38621137

Title: Threonine phosphorylation of STAT1 restricts interferon signaling and promotes innate inflammatory responses.

PubMed ID: 38621137

DOI: 10.1073/pnas.2402226121

PubMed ID: 18462684

Title: Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.

PubMed ID: 18462684

DOI: 10.1016/j.str.2008.02.012

PubMed ID: 16959974

Title: The consensus coding sequences of human breast and colorectal cancers.

PubMed ID: 16959974

DOI: 10.1126/science.1133427

PubMed ID: 17344846

Title: Patterns of somatic mutation in human cancer genomes.

PubMed ID: 17344846

DOI: 10.1038/nature05610

Sequence Information:

  • Length: 756
  • Mass: 86564
  • Checksum: F9CADF671AE9E14E
  • Sequence:
  • MSWSPSLTTQ TCGAWEMKER LGTGGFGNVI RWHNQETGEQ IAIKQCRQEL SPRNRERWCL 
    EIQIMRRLTH PNVVAARDVP EGMQNLAPND LPLLAMEYCQ GGDLRKYLNQ FENCCGLREG 
    AILTLLSDIA SALRYLHENR IIHRDLKPEN IVLQQGEQRL IHKIIDLGYA KELDQGSLCT 
    SFVGTLQYLA PELLEQQKYT VTVDYWSFGT LAFECITGFR PFLPNWQPVQ WHSKVRQKSE 
    VDIVVSEDLN GTVKFSSSLP YPNNLNSVLA ERLEKWLQLM LMWHPRQRGT DPTYGPNGCF 
    KALDDILNLK LVHILNMVTG TIHTYPVTED ESLQSLKARI QQDTGIPEED QELLQEAGLA 
    LIPDKPATQC ISDGKLNEGH TLDMDLVFLF DNSKITYETQ ISPRPQPESV SCILQEPKRN 
    LAFFQLRKVW GQVWHSIQTL KEDCNRLQQG QRAAMMNLLR NNSCLSKMKN SMASMSQQLK 
    AKLDFFKTSI QIDLEKYSEQ TEFGITSDKL LLAWREMEQA VELCGRENEV KLLVERMMAL 
    QTDIVDLQRS PMGRKQGGTL DDLEEQAREL YRRLREKPRD QRTEGDSQEM VRLLLQAIQS 
    FEKKVRVIYT QLSKTVVCKQ KALELLPKVE EVVSLMNEDE KTVVRLQEKR QKELWNLLKI 
    ACSKVRGPVS GSPDSMNASR LSQPGQLMSQ PSTASNSLPE PAKKSEELVA EAHNLCTLLE 
    NAIQDTVREQ DQSFTALDWS WLQTEEEEHS CLEQAS